Profile
Full Name
Xenon Pharmaceuticals Inc.Ticker Symbol
XENEExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
CanadaIPO
November 5, 2014Indexes
Not includedWebsite
http://www.xenon-pharma.comEmployees
316Key Details
Price
$38.06(+1.17%)
Market cap
$2.91B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$3.01(-10.26% YoY)
Next earnings date
May 9, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Xenon Pharmaceuticals doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 17, 25 Goldman Sachs
BuyFeb 24, 25 HC Wainwright & Co.
BuyFeb 11, 25 Deutsche Bank
BuyDec 12, 24 HC Wainwright & Co.
BuyNov 13, 24 Needham
BuyNov 13, 24 HC Wainwright & Co.
BuyOct 1, 24 HC Wainwright & Co.
BuySep 3, 24 RBC Capital
OutperformAug 12, 24 Needham
BuyAug 9, 24 Wedbush
OutperformInstitutional Ownership
- What is the ticker symbol for Xenon Pharmaceuticals?
- Does Xenon Pharmaceuticals pay dividends?
- What sector is Xenon Pharmaceuticals in?
- What industry is Xenon Pharmaceuticals in?
- What country is Xenon Pharmaceuticals based in?
- When did Xenon Pharmaceuticals go public?
- Is Xenon Pharmaceuticals in the S&P 500?
- Is Xenon Pharmaceuticals in the NASDAQ 100?
- Is Xenon Pharmaceuticals in the Dow Jones?
- When was Xenon Pharmaceuticals's last earnings report?
- When does Xenon Pharmaceuticals report earnings?
- Should I buy Xenon Pharmaceuticals stock now?
What is the ticker symbol for Xenon Pharmaceuticals?
The ticker symbol for Xenon Pharmaceuticals is NASDAQ:XENE
Does Xenon Pharmaceuticals pay dividends?
No, Xenon Pharmaceuticals does not pay dividends
What sector is Xenon Pharmaceuticals in?
Xenon Pharmaceuticals is in the Healthcare sector
What industry is Xenon Pharmaceuticals in?
Xenon Pharmaceuticals is in the Biotechnology industry
What country is Xenon Pharmaceuticals based in?
Xenon Pharmaceuticals is headquartered in Canada
When did Xenon Pharmaceuticals go public?
Xenon Pharmaceuticals's initial public offering (IPO) was on November 5, 2014
Is Xenon Pharmaceuticals in the S&P 500?
No, Xenon Pharmaceuticals is not included in the S&P 500 index
Is Xenon Pharmaceuticals in the NASDAQ 100?
No, Xenon Pharmaceuticals is not included in the NASDAQ 100 index
Is Xenon Pharmaceuticals in the Dow Jones?
No, Xenon Pharmaceuticals is not included in the Dow Jones index
When was Xenon Pharmaceuticals's last earnings report?
Xenon Pharmaceuticals's most recent earnings report was on Feb 27, 2025
When does Xenon Pharmaceuticals report earnings?
The next expected earnings date for Xenon Pharmaceuticals is May 9, 2025
Should I buy Xenon Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions